Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Yarnold

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1992
Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients' ratings, observers' ratings, and objective assessmentsK C Sneeuw, N K Aaronson, J R Yarnold, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 4, 1998
The effectiveness of the routine clinic visit in the follow-up of breast cancer patients: analysis of a defined patient cohortS Loong, M Wilkins, J M Bliss, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1992
Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 2. Relationship with psychosocial functioningK C Sneeuw, N K Aaronson, J R Yarnold, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 3, 2013
Multileaf collimation cardiac shielding in breast radiotherapy: Cardiac doses are reduced, but at what cost?F R Bartlett, J R Yarnold, E M Donovan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 1988
Carboplatin (JM8), etoposide (VP16) and thoracic irradiation for small cell lung cancer (S.C.L.C.): an evaluation of lung toxicityJ Glaholm, L Repetto, J R Yarnold, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 1997
Dosimetric evaluation of compensation in radiotherapy of the breast: MLC intensity modulation and physical compensatorsV N Hansen, P M Evans, G S Shentall, et al.
Radiation Research|July 3, 1998
Comparison between pulsed-field gel electrophoresis and the comet assay as predictive assays for radiosensitivity in fibroblastsJ N Sarkaria, C Bush, J J Eady, et al.
The British Journal of Radiology|March 18, 2008
An investigation into methods of IMRT planning applied to breast radiotherapyE M Donovan, J R Yarnold, E J Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancerI E Smith, T J Perren, S A Ashley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 23, 2021
Five-fraction Radiotherapy for Breast Cancer: FAST-Forward to ImplementationA M Brunt, J S Haviland, A M Kirby, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1992
Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients' ratings, observers' ratings, and objective assessmentsK C Sneeuw, N K Aaronson, J R Yarnold, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 4, 1998
The effectiveness of the routine clinic visit in the follow-up of breast cancer patients: analysis of a defined patient cohortS Loong, M Wilkins, J M Bliss, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1992
Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 2. Relationship with psychosocial functioningK C Sneeuw, N K Aaronson, J R Yarnold, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 3, 2013
Multileaf collimation cardiac shielding in breast radiotherapy: Cardiac doses are reduced, but at what cost?F R Bartlett, J R Yarnold, E M Donovan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 1988
Carboplatin (JM8), etoposide (VP16) and thoracic irradiation for small cell lung cancer (S.C.L.C.): an evaluation of lung toxicityJ Glaholm, L Repetto, J R Yarnold, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 1997
Dosimetric evaluation of compensation in radiotherapy of the breast: MLC intensity modulation and physical compensatorsV N Hansen, P M Evans, G S Shentall, et al.
Radiation Research|July 3, 1998
Comparison between pulsed-field gel electrophoresis and the comet assay as predictive assays for radiosensitivity in fibroblastsJ N Sarkaria, C Bush, J J Eady, et al.
The British Journal of Radiology|March 18, 2008
An investigation into methods of IMRT planning applied to breast radiotherapyE M Donovan, J R Yarnold, E J Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancerI E Smith, T J Perren, S A Ashley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 23, 2021
Five-fraction Radiotherapy for Breast Cancer: FAST-Forward to ImplementationA M Brunt, J S Haviland, A M Kirby, et al.
Pageof 10